FDA Inspection 1026803 — Lyne Laboratories, Inc.

Lyne Laboratories, Inc. — FEI 1000513191

The FDA completed an inspection of Lyne Laboratories, Inc. on September 7, 2017 in Brockton, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 7, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Brockton, MA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)